The trademark application was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on November 9, 2020, and it was registered by office on February 16, 2021 without any oppositions.
The application was filed in English (Spanish was selected as the second language).